e-learning
resources
Madrid 2019
Monday, 30.09.2019
Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of obesity in patients with sarcoidosis
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Lysenko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation)
Source:
International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session:
Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Session type:
Poster Discussion
Number:
1951
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Sholomova (Moscow, Russian Federation), M. Brovko (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), L. Lysenko (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation), L. Samokhodskaya (Moscow, Russian Federation), T. Krasnova (Moscow, Russian Federation). The role of obesity in patients with sarcoidosis. 1951
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The prognostic role of the bronchiectasis in patients with COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Prevalence of metabolic syndrome in women asthma patients: role of adipokines
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
The role of obesity
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Is OSA an important risk factor for metabolic dysregulation in obese COPD patients
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Long-term prognosis of new adult-onset asthma in obese patients
Source: Eur Respir J, 57 (4) 2001209; 10.1183/13993003.01209-2020
Year: 2021
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Microbiome landscape and disease duration role in allergy in adult patients with bronchiectasis
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
The effect of obesity and central obesity on pulmonary function of asthmatics
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008
The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Comorbidities in asthma: the role of obesity in children with asthma
Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents?
Year: 2020
The role of biomarkers in the management of severe asthma
Source: International Congress 2019 – Severe asthma guidelines: update 2019
Year: 2019
The role of the constitution factors and some blood antigens in the development of osteoporosis in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 324s
Year: 2006
The role of leptin and adiponectin in patients with COPD
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
The role of personality traits in the pulmonary rehabilitation response in COPD patients
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021
Comparison of BMI and central obesity between asthma and COPD patients
Source: Annual Congress 2008 - Issues in the management of COPD in the community
Year: 2008
The role of nonspecific inflammation factors – SA-A and pentraxin-3 in patients with respiratory sarcoidosis in different age groups
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021
The pivotal role of nurses in educating patients with pulmonary hypertension
Source: Annual Congress 2008 - Future management of pulmonary arterial hypertension
Year: 2008
Features of adipokine regulation at young patients with bronchial asthma with different phenotypes of obesity
Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept